Periprocedural myocardial injury and myocardial infarction (MI) are not infrequent
complications of percutaneous coronary intervention (PCI) and are associated with greater …

Minor myocardial injury (MMI), identified by elevated serum levels of cardiac markers, is not
uncommon after successful, uncomplicated elective percutaneous coronary intervention …

Background: Periprocedural myocardial infarction and injury (PM-injury) are the most
common complications of percutaneous coronary intervention (PCI) and are associated with …

There is robust information that confirms the enormous contribution of inflammation to
plaque development, progression and vulnerability. The presence of plaques with …

The introduction of percutaneous coronary interventions (PCI) with stent implant has
substantially shifted the treatment of coronary artery disease. The current approach to …

Restenosis after stent implantation is mainly caused by neointimal proliferation through the
stent struts. Experimental studies performed in the last decade indicate that inflammatory …

Background: Inflammation after coronary stenting presages adverse outcomes after
percutaneous coronary intervention (PCI). While changes in inflammatory markers have …

The development of coronary stent has revolutionized the field of interventional cardiology
by reducing the incidence of restenosis after balloon angioplasty. Despite significant …

Background: Vascular injury and inflammation during percutaneous coronary intervention
(PCI) are associated with increased risk of post-PCI adverse outcomes. Colchicine …

Vascular inflammation is central to the pathogenesis of acute coronary syndromes (ACS)
and the response to vascular injury after percutaneous coronary intervention (PCI). For both …